Cargando…
Surgical Management of Secondary Hyperparathyroidism
Secondary hyperparathyroidism (SHPT) affects a majority of patients with chronic kidney disease (CKD) of stage 3 or worse. Despite the development of calcimimetics and their effectiveness in treating SHPT, many patients continue to fail medical management and should be referred to a parathyroid surg...
Autores principales: | Steinl, Gabrielle K., Kuo, Jennifer H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879113/ https://www.ncbi.nlm.nih.gov/pubmed/33615051 http://dx.doi.org/10.1016/j.ekir.2020.11.023 |
Ejemplares similares
-
Patients With Primary Hyperparathyroidism Have Shorter QT/QTc Intervals
por: Stewart, Latoya A, et al.
Publicado: (2021) -
Reoperation for persistent or recurrent secondary hyperparathyroidism. Surgical treatment of renal hyperparathyroidism
por: Abruzzo, Alida, et al.
Publicado: (2017) -
Recent Trends in the Surgical Treatment of Secondary Hyperparathyroidism
por: Won, Ho-Ryun, et al.
Publicado: (2020) -
Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2020) -
Surgical management of primary hyperparathyroidism in Canada
por: Williams, Blair A, et al.
Publicado: (2014)